William Blair research analyst Matt Phipps was quoted in this CNBC outlook story covering how healthcare stocks will perform in 2023.
“Several companies that had provided strong clinical data were able to raise funds [in 2022],” Phipps said.
Equity Research
Matt Phipps Quoted in CNBC
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
On Holding AG: Initiation of Research Coverage
William Blair initiated research coverage of On Holding AG (ONON $32.87), a fast-growing performance and lifestyle brand based in Switzerland selling athletic footwear, primarily in running, but with a growing presence in newer categories and apparel.
Read moreLife After Employee Benefits
In addition to retirement considerations, any employee preparing to leave a job should plan for life after employee benefits.
Read moreCullinan Oncology, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Cullinan Oncology, Inc. (CGEM $17.37), a company focused on advancing modality-agnostic targeted therapies for cancer, with a broad pipeline encompassing small molecules and multifunctional therapies across a diverse range of oncologic targets.
Read more